Directed differentiation of induced pluripotent stem cells towards t lymphocytes

Journal of Visualized Experiments

Volumn , Issue 63, 2012, Pages 1-

  Lei, Fengyang ^a   Haque, Rizwanul ^a   Xiong, Xiaofang ^a   Song, Jianxun ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Adoptive cell transfer; Differentiation; Immunology; Induced pluripotent stem cells; Issue 63; Notch signaling; Stem cell biology; T cell receptor; T cells

Indexed keywords

EID: 84863734524     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/3986     Document Type: Article

References (18)

1. Brenner, M.K. & Heslop, H.E. Adoptive T cell therapy of cancer. Curr. Opin. Immunol. 22, 251-257 (2010).
2. Hataye, J., Moon, J.J., Khoruts, A., Reilly, C., & Jenkins, M. K. Naive and memory CD4+ T cell survival controlled by clonal abundance. Science. 312, 114-116 (2006).
3. Seki, Y., et al. IL-7/STAT5 cytokine signaling pathway is essential but insufficient for maintenance of naive CD4 T cell survival in peripheral lymphoid organs. J. Immunol. 178, 262-270 (2007).
4. Stemberger, C., et al. A single naive CD8+ T cell precursor can develop into diverse effector and memory subsets. Immunity. 27, 985-997 (2007).
5. Siewert, C., et al. Experience-driven development: effector/memory-like alphaE+Foxp3+ regulatory T cells originate from both naive T cells and naturally occurring naive-like regulatory T cells. J. Immunol. 180, 146-155 (2008).
6. Wang, L.X. & Plautz, G.E. Tumor-primed, in vitro-activated CD4+ effect or T cells establish long-term memory without exogenous cytokine support or ongoing antigen exposure. J. Immunol. 184, 5612-5618 (2010).
7. Hinrichs, C.S., et al. Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy. Blood. 117, 808-814 (2011).
8. Alajez, N.M., Schmielau, J., Alter, M.D., Cascio, M., & Finn, O. J. Therapeutic potential of a tumor-specific, MHC-unrestricted T-cell receptor expressed on effect or cells of the innate and the adaptive immune system through bone marrow transduction and immune reconstitution. Blood. 105, 4583-4589 (2005).
9. Yang, L. & Baltimore, D. Long-term in vivo provision of antigen-specific T cell immunity by programming hematopoietic stem cells. Proc. Natl. Acad. Sci. U.S.A. 102, 4518-4523 (2005).
10. Zhao, Y., et al. Extra thymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via Notch signaling. Cancer Res. 67, 2425-2429 (2007).
11. Boztug, K., et al. Stem-cell gene therapy for the Wiskott-Aldrich syndrome. N. Engl. J. Med. 363, 1918-1927 (2010).
12. Peerani, R. & Zandstra, P.W. Enabling stem cell therapies through synthetic stem cell-niche engineering. J. Clin. Invest. 120, 60-70 (2010).
13. Mendez-Ferrer, S., et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature. 466, 829-834 (2010).
14. Daley, G.Q. Towards he generation of patient-specific pluripotent stem cells for combined gene and cell therapy of hematologic disorders. Hematology Am. Soc. Hematol. Educ. Program. 17-22 (2007).
15. Boitano, A.E., et al. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science. 329, 1345-1348 (2010).
16. Himburg, H.A., et al. Pleiotrophin regulates the expansion and regeneration of hematopoietic stem cells. Nat. Med. 16, 475-482 (2010)
17. Tanigaki, K. & Honjo, T. Regulation of lymphocyte development by Notch signaling. Nature immunology. 8, 451-456 (2007).
18. Zhao, T., Zhang, Z.N., Rong, Z., & Xu, Y. Immunogenicity of induced pluripotent stem cells. Nature. 474, 212-215 (2011).